Related Experiment Video
Updated: Jun 12, 2025

Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
Animal Models: A Tool for Colon Cancer Research
LokeshKumar Boopathy1, Sasikumar Arumugam2, Kumar Ponnusamy3
1Centre for Laboratory Animal Technology & Research, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Abstract:
Preclinical animal research plays a crucial role in studying colorectal cancer (CRC). Mouse models allow for testing the efficacy of potential medications and understanding the mechanisms behind CRC development. Carcinogens like 1,2-Dimethylhydrazine (DMH) and Azoxymethane (AOM) are used to induce CRC in these models, enabling researchers to investigate various treatment approaches. The availability of diverse animal strains facilitates the study of CRC progression and metastasis. By examining literature on animal models, researchers can assess the accuracy of reproducing different stages of CRC, from crypts to polyps and tumors. Animal models are essential for studying the tumor microenvironment and its impact on CRC. These models replicate key features of human CRC, including angiogenesis and immune responses. Both immunocompetent and immunocompromised rodents are used to evaluate immunotherapeutic drugs. This review summarizes common murine models for CRC and their applications in translational research. Future trends in this field likely include further advancements in animal models for studying tumor biology.
Insights
Preclinical animal models are vital for colorectal cancer (CRC) research, aiding drug testing and understanding disease mechanisms. This review covers common mouse models used in translational studies for CRC.
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Preclinical animal research, particularly using mouse models, is fundamental for advancing colorectal cancer (CRC) understanding.
- Models utilizing carcinogens like 1,2-Dimethylhydrazine (DMH) and Azoxymethane (AOM) are key for inducing CRC and studying its development.
- Diverse animal strains and the examination of literature are crucial for assessing the fidelity of CRC stage replication in models.
Purpose of the Study:
- To review and summarize common murine models employed in colorectal cancer (CRC) research.
- To highlight the applications of these animal models in translational research for CRC.
- To discuss the role of animal models in understanding CRC mechanisms, tumor microenvironment, and treatment efficacy.
Main Methods:
- Literature review of preclinical studies involving animal models for colorectal cancer (CRC).
- Analysis of common carcinogen-induced and genetically engineered mouse models for CRC.
- Evaluation of how different animal models replicate human CRC features, including tumor progression and the tumor microenvironment.
Main Results:
- Murine models effectively replicate key aspects of human colorectal cancer (CRC), including angiogenesis and immune responses.
- Both immunocompetent and immunocompromised rodents are utilized for evaluating novel therapeutic strategies, including immunotherapies.
- The reviewed models provide valuable platforms for studying CRC progression, metastasis, and the tumor microenvironment.
Conclusions:
- Animal models, especially murine models, are indispensable tools for preclinical colorectal cancer (CRC) research and drug development.
- These models facilitate the investigation of CRC mechanisms, the tumor microenvironment, and the efficacy of various treatment modalities.
- Continued advancements in animal models are expected to further enhance the study of tumor biology and accelerate translational research in CRC.

